ARTICLE | Company News
Gilead licenses SELEX to Archemix
October 23, 2001 7:00 AM UTC
GILD exclusively licensed its systemic evolution of ligands through exponential enrichment (SELEX) technology to Archemix ( Cambridge, Mass.) for $17.5 million in cash plus Archemix warrants. SELEX pr...